bulk vaccine
Scope
Date
~
-
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Lemonex signs MOU with WHO mRNA vaccines tech hub
South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...
May 09, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to produce MSD’s new Ebola vaccine candidate
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...
May 08, 2023 (Gmt+09:00)
-
Batteries
POSCO Future M to inject $461 mn to bulk up cathode production
POSCO Future M Co., a unit of South Korean steel giant POSCO Holdings Inc., said on Monday it has decided to invest 614.8 billion won ($460.5 millio...
Apr 24, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins $44 mn flu vaccine order from WHO agency
South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a d...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's licensed flu vaccine gets approval in Taiwan
South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the ...
Mar 13, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Korean chipmakers
S.Korea's DB HiTek to split off fabless, bulk up foundry business
DB HiTek Co., a leading chipmaker in South Korea, said on March 7 it is set to split off its fabless unit by May 2 to ramp up its foundry business.D...
Mar 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's EuBiologics to receive support from Gates Foundation
South Korea's biopharmaceutical company EuBiologics Co. announced on Wednesday that its meningococcal pentavalent conjugate vaccine EuMCV5 under dev...
Feb 23, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine
South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter th...
Feb 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Ochang facility gets WHO PQ certification
GC Biopharma Co.'s production facility in Ochang (North Chungcheong Province) secured a pre-qualification (PQ) certification from the World Health O...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Red ginseng prevents flu, pneumonia: research
Studies have shown that South Korea's hongsam (red ginseng) is effective in preventing respiratory diseases such as the flu and pneumonia.The Korean...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved by Chilean health authority
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, announced on Thursday that its world-first cell culture-based quadr...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's shingles vaccine obtains product approval from Malaysia
SK Bioscience Co. said on Monday that its shingles vaccine Sky Zoster has been given approval by Malaysia's National Pharmaceutical Regulatory Age...
Jan 09, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Pan Ocean to transport energy products for Portugal's Galp
Pan Ocean Co., the top bulk shipping company in South Korea, has received its first large-scale liquefied natural gas (LNG) carrier to provide shipp...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB Therapeutics signs contract for COVID vaccine distribution rights
South Korea's pharmaceutical firm HLB Therapeutics Co. said on Monday that it has signed an agreement with the Korea Disease Control and Prevention ...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Logistics
CJ Logistics expands global e-commerce shipping services
South Korea’s CJ Logistics Corp. is ramping up its cross-border e-commerce (CBE) businesses as its local rival Coupang Inc. is increasing domi...
Dec 14, 2022 (Gmt+09:00)
-
Artificial intelligence
LG Group think tank unveils breakthrough AI tech Exaone
LG AI Research, the artificial intelligence (AI) think tank of South Korea's LG Group, on Thursday unveiled Exaone, a gigantic AI technology that ra...
Dec 09, 2022 (Gmt+09:00)
-
ESG
SK Inc. bulks up green investments to achieve net zero by 2035
SK Inc., the investment arm of South Korea’s second-largest conglomerate SK Group, is taking preemptive steps to expand its eco-friendly busin...
Dec 01, 2022 (Gmt+09:00)
-
Retail
Lotte Mart bulks up in SE Asia to make up for China failure
Indonesia was the destination for Lotte Group Chairman Shin Dong-bin’s first overseas business trip in August, after being granted a special p...
Nov 07, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience seeks WHO nod for prompt COVID vaccine sale
SK Bioscience Co., the biopharmaceutical unit of South Korea’s No. 2 conglomerate SK Group, sought approval from the World Health Organization...
Sep 08, 2022 (Gmt+09:00)
-
Blockchain
S. Korea's digital asset exchange operators bulk up despite crypto winter
Despite being in crypto winter, or a period in which prices of major cryptocurrencies have slid and stayed low for weeks on end, South Korea's bigge...
Aug 17, 2022 (Gmt+09:00)
-
Cloud computing
KT ups ante with $1.5 billion spending on public sector cloud service
KT Cloud Corp., a unit of South Korea’s telecom giant KT Corp., plans to spend up to 2 trillion won ($1.5 billion) over the next three years t...
Jul 29, 2022 (Gmt+09:00)
-
Corporate investment
Korea to raise cash support on foreign investments in key sectors
South Korea plans to spend more cash on attracting foreign investments in high-tech and core supply chain industries as foreign direct investment to...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language -
Real estate
Korea's top real estate managers bulk up assets in COVID-19
Real estate funds in South Korea have increased by 27% to 130 trillion won ($101.4 billion) from 102 trillion won over the past two years, accordi...
May 13, 2022 (Gmt+09:00)
-
Steel
Dongkuk buys 15% stake in Vietnamese steel fabricator
Dongkuk Steel Mill Co., South Korea’s leading color-coated steel manufacturer, said on Wednesday it has acquired a 15% stake in VSSC Steel Cen...
Apr 27, 2022 (Gmt+09:00)